A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A 2A -Receptor Agonist, in Healthy Male Volunteers

By Gordi Toufigh  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1201-1212

Adis International

Access to resources Recommend Favorite

Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone: A Study in Healthy Volunteers

By Yassen Ashraf  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 965-980

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Modelling of Arterial Haemodynamic Effects of Terazosin in Healthy Volunteers

By Miguel Angel Campanero   Sádaba Belén   Muñoz-Juarez Maria José   Quetglas Emilio García   Azanza Jose Ramón  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 139-147

Adis International

Access to resources Recommend Favorite

Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 305-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers

By Fleishaker J.C.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite